Tessa Brik1, Lieke J J J Vrouenraets2, Sebastian E E Schagen1, Andreas Meissner3, Martine C de Vries1, Sabine E Hannema4. 1. Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands. 2. Department of Pediatric Psychology, Curium-Leiden University Medical Center, Leiden, The Netherlands. 3. Center for Reproductive Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. 4. Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: S.E.Hannema@lumc.nl.
Abstract
PURPOSE: The primary aims of the study are to examine the rate of attempted fertility preservation (FP) among a Dutch cohort of transgirls who started gonadotropin-releasing hormone analog treatment and the reasons why adolescents did or did not choose to attempt FP. METHODS: The study was a single-center retrospective review of medical records of 35 transgirls who started gonadotropin-releasing hormone analog treatment between 2011 and 2017. RESULTS: Ninety-one percent of adolescents were counseled on the option of FP. Thirty-eight percent of counseled adolescents attempted FP, and 75% of them were able to cryopreserve sperm suitable for intrauterine insemination or intracytoplasmic sperm injection. Younger and Caucasian transgirls were less likely to attempt FP. No specific reason for declining FP was known in 33% adolescents, 32% of adolescents were not able to produce a semen sample because of early puberty, 17% felt uncomfortable with masturbation, 17% did not want to have children, and 13% wanted to adopt. CONCLUSIONS: One third of adolescents attempted FP, which is much more than the percentage reported in previous studies from the United States. One third of the transgirls could not make use of FP because they were unable to produce a semen sample because of early pubertal stage. For these adolescents, alternatives need to be explored.
PURPOSE: The primary aims of the study are to examine the rate of attempted fertility preservation (FP) among a Dutch cohort of transgirls who started gonadotropin-releasing hormone analog treatment and the reasons why adolescents did or did not choose to attempt FP. METHODS: The study was a single-center retrospective review of medical records of 35 transgirls who started gonadotropin-releasing hormone analog treatment between 2011 and 2017. RESULTS: Ninety-one percent of adolescents were counseled on the option of FP. Thirty-eight percent of counseled adolescents attempted FP, and 75% of them were able to cryopreserve sperm suitable for intrauterine insemination or intracytoplasmic sperm injection. Younger and Caucasian transgirls were less likely to attempt FP. No specific reason for declining FP was known in 33% adolescents, 32% of adolescents were not able to produce a semen sample because of early puberty, 17% felt uncomfortable with masturbation, 17% did not want to have children, and 13% wanted to adopt. CONCLUSIONS: One third of adolescents attempted FP, which is much more than the percentage reported in previous studies from the United States. One third of the transgirls could not make use of FP because they were unable to produce a semen sample because of early pubertal stage. For these adolescents, alternatives need to be explored.
Authors: Maria Yan; Samyd S Bustos; Doga Kuruoglu; Pedro Ciudad; Antonio J Forte; Esther A Kim; Gabriel Del Corral; Oscar J Manrique Journal: Ann Transl Med Date: 2021-04
Authors: Lieke Josephina Jeanne Johanna Vrouenraets; Annelou L C de Vries; Marijn Arnoldussen; Sabine E Hannema; Ramón J L Lindauer; Martine C de Vries; Irma M Hein Journal: Eur Child Adolesc Psychiatry Date: 2022-09-17 Impact factor: 5.349
Authors: Angus Peri; Astrid Ahler; Debra Gook; Michele A O'Connell; Harold Bourne; Michael Nightingale; Michelle Telfer; Yasmin Jayasinghe; Ken C Pang Journal: J Assist Reprod Genet Date: 2021-08-23 Impact factor: 3.357
Authors: Benjamin P Jones; Abirami Rajamanoharan; Saaliha Vali; Nicola J Williams; Srdjan Saso; Meen-Yau Thum; Sadaf Ghaem-Maghami; Isabel Quiroga; Cesar Diaz-Garcia; Philip Thomas; Stephen Wilkinson; Joseph Yazbek; J Richard Smith Journal: JAMA Netw Open Date: 2021-01-04